Search Count: 27
 |
Potential Drug Binding Sites For Translation Initiation Factor Eif4E
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2025-01-15 Classification: TRANSLATION Ligands: DMS, PGE, W5B |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: DMS, PGE, W5B
 |
Potential Drug Binding Sites For Translation Initiation Factor Eif4E
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2025-01-15 Classification: TRANSLATION Ligands: W4U, PGE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: W4U, PGE
 |
Potential Drug Binding Sites For Translation Initiation Factor Eif4E
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2025-01-15 Classification: TRANSLATION Ligands: DMS, W2N, W4B, PEG, PGE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: DMS, W2N, W4B, PEG, PGE
 |
Potential Drug Binding Sites For Translation Initiation Factor Eif4E
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2025-01-15 Classification: TRANSLATION Ligands: DMS, PGE, W5K, PEG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: DMS, PGE, W5K, PEG
 |
Potential Drug Binding Sites For Translation Initiation Factor Eif4E
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2025-01-15 Classification: TRANSLATION Ligands: PEG, PGE, W4K, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: PEG, PGE, W4K, DMS
 |
Potential Drug Binding Sites For Translation Initiation Factor Eif4E
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2025-01-15 Classification: TRANSLATION Ligands: EDO, PEG, DMS, W4K |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-15
Ligands: EDO, PEG, DMS, W4K
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, UMN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, DMS, UMN
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, UNW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, DMS, UNW
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UO5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, UO5
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UOH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, UOH
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, EDO, UOE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, DMS, EDO, UOE
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UOW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, UOW
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, EQT
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, EQW
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERZ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ERZ
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EU2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, EU2
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQZ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, EQZ
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESQ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ESQ
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ER8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ER8
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ERW